MedTrace Logo

CBT Through Internet and Smartphones for Adults With ADHD - a Randomized Controlled Trial

NCT02041884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2020-01-07

No results posted yet for this study

Summary

The purpose of this study is to further evaluate the treatment for adults with ADHD used in our previous study (clinicaltrials.gov ID NCT01659164). It will now be converted to therapist supported, internet-delivered cognitive behavioral therapy (iCBT) with an additional smartphone application and evaluated through a randomized controlled trial during 12 weeks. The patients will be randomized to one of three conditions

* an active treatment group where the intervention is based on cognitive - and dialectical behavioral therapy (CBT and DBT) and the mobile app.
* an active ICBT-treatment based on psychoeducation, a CBT stress-reduction program and Applied Relaxation, and
* treatment as usual (TAU) / waiting list.

The main objective of the study is to evaluate if both of the treatment conditions will show better outcomes than TAU regarding decreased ADHD symptoms and increased functioning and life quality.

Another objective is to evaluate if the group receiving the active iCBT treatment (based on CBT and DBT) will show better outcomes in comparison to the control group regarding ADHD symptoms, overall functioning and life quality.

Conditions

  • ADHD

Interventions

BEHAVIORAL

iCBT for Adults with ADHD

A skill training internet-based treatment program based on CBT and DBT interventions .

BEHAVIORAL

Internet stress-reduction

Internet-based psychoeducation, stress-reduction, and Applied Relaxation based on CBT (control group)

OTHER

Treatment as usual (TAU)/waiting list

Treatment as usual (usually medications for ADHD), will be offered treatment after the FU3 (week 24)

Sponsors & Collaborators

Principal Investigators

  • Viktor Kaldo, PhD/Ass prof · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041884 on ClinicalTrials.gov